Social Capital: GLP-1 Duopoly Revenue ~2x OpenAI and Anthropic Combined

FinanceYF5 · x · 2026-10-12

Quoting Social Capital's data post: in 2025, the two biggest GLP-1 drugs generated roughly 2x the combined revenue of OpenAI and Anthropic. The author reiterates that while attention is fixed on AI, GLP-1 has quietly become the larger commercial wave, with impact reaching well beyond weight loss.

Related event: Top GLP-1 Drugs Out-Earn OpenAI and Anthropic Combined(3 posts)→

Original post →

More from Venture

Venture channel →